Atara Biotherapeutics, Inc. (ATRA): Depreciation & Amortization
$2.12M
Year ended 2025-12-31
$128.0K
Trailing 12 months to 2026-06-30
-27.9%
3-year compound annual growth
-24.0%
5-year compound annual growth
+46.0%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.12M | -58.1% | 2026-03-16, From 2025-01-01 |
| 2024-12-31 | $5.05M | +4.6% | 2026-03-16, From 2024-01-01 |
| 2023-12-31 | $4.83M | -14.6% | 2025-03-07, From 2023-01-01 |
| 2022-12-31 | $5.65M | -39.5% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $9.35M | +12.2% | 2023-02-08, From 2021-01-01 |
| 2020-12-31 | $8.33M | +17.9% | 2023-02-08, From 2020-01-01 |
| 2019-12-31 | $7.07M | +89.4% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $3.73M | +290.4% | 2021-03-01, From 2018-01-01 |
| 2017-12-31 | $956.0K | +149.6% | 2020-02-27, From 2017-01-01 |
| 2016-12-31 | $383.0K | +697.9% | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | $48.0K | n/a | 2018-02-27, From 2015-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Atara Biotherapeutics, Inc. (ATRA) | 2025-12-31 | $2.12M | -58.1% |
| Agenus Inc (AGEN) | 2025-12-31 | $10.00M | -25.1% |
| ImmunityBio, Inc. (IBRX) | 2025-12-31 | $15.53M | -11.6% |
| Beam Therapeutics Inc. (BEAM) | 2025-12-31 | $22.29M | +1.7% |
| Sutro Biopharma, Inc. (STRO) | 2025-12-31 | $7.32M | +1.5% |
| Ginkgo Bioworks Holdings, Inc. (DNA) | 2025-12-31 | $58.99M | -6.4% |
| REGENXBIO Inc. (RGNX) | 2025-12-31 | $15.62M | -3.7% |
| 4D Molecular Therapeutics, Inc. (FDMT) | 2025-12-31 | $4.69M | +0.9% |
| MeiraGTx Holdings plc (MGTX) | 2025-12-31 | $12.54M | -2.2% |
Compare ATRA, AGEN, IBRX, BEAM side by side · Screen every company in Biological Products, (No Diagnostic Substances) ↗